India Advances to Futuristic Healthcare with Genomics and Personalised Medicine Initiatives

Union Minister Jitendra Singh announced India's transition to a futuristic healthcare model focused on genomics and personalised medicine. He emphasised the importance of early detection and affordability in tackling genetic diseases, highlighting significant advancements in molecular diagnostics and genome sequencing.

Union Minister Jitendra Singh highlighted the challenges of early detection and affordability in tackling genetic and rare diseases. He stated that India is now equipped to handle complex health issues using genomics, biotechnology, and preventive healthcare. Singh, who is the Union MoS Independent Charge for Science and Technology, noted that the country has moved beyond infectious diseases to focus on molecular diagnostics and personalised medicine.

During a visit to the Centre for DNA Fingerprinting and Diagnostics (CDFD), Singh emphasised the importance of institutions like CDFD in connecting laboratory research with clinical outcomes. He observed India's rapid progress in genomics, including large-scale genome sequencing and paediatric genetic disease programmes. These initiatives are paving the way for personalised treatments, where patients with similar conditions may need different therapies.

Genomics and Biotechnology Advancements

Singh discussed India's first National Policy for Rare Diseases introduced in 2021, which marked a significant shift in government strategy. This policy reflects a willingness to incorporate scientific insights into healthcare planning. However, he stressed that detection alone is insufficient; affordable treatment options must also be available for affected families.

The minister highlighted India's expanding bio-economy, noting a significant increase in biotech startups and their economic contributions. The establishment of the Biotechnology Research and Innovation Council (BRIC) has enhanced coordination among institutions, fostering impactful research and industry collaboration.

Government Initiatives and Future Prospects

Singh reviewed ongoing research at CDFD and praised initiatives like genome sequencing programmes aimed at raising public awareness. He mentioned that under Prime Minister Narendra Modi's leadership, biotechnology and health have received unprecedented attention. The Bio-E3 Policy announced during Independence Day has sparked interest among scientists, startups, and young innovators nationwide.

During his visit to CDFD, Singh also laid the foundation stone for the National Skill Development Centre, SAMARTH. This initiative aims to enhance skill development in biotechnology and related fields, further strengthening India's capabilities in these areas.

The minister's remarks underscore India's readiness to address complex health challenges through scientific advancements. With a focus on genomics and biotechnology, the country is poised to improve healthcare delivery significantly. This progress is expected to benefit patients by providing more targeted and effective treatments.

With inputs from PTI